Latest Expert Exchange Queries
sitemapHome | Registration | Job Portal for CA's | Expert Exchange | Currency Converter | Post Matrimonial Ads | Post Property Ads
News shortcuts: From the Courts | News Headlines | VAT (Value Added Tax) | Service Tax | Sales Tax | Placements & Empanelment | Various Acts & Rules | Latest Circulars | New Forms | Forex | Auditing | Direct Tax | Customs and Excise | ICAI | Corporate Law | Markets | Students | General | Indirect Tax | Mergers and Acquisitions | Continuing Prof. Edu. | Budget Extravaganza | Transfer Pricing
Popular Search: ACCOUNTING STANDARDS :: cpt :: TDS :: VAT RATES :: TAX RATES - GOODS TAXABLE @ 4% :: list of goods taxed at 4% :: empanelment :: Central Excise rule to resale the machines to a new company :: due date for vat payment :: form 3cd :: ICAI offer Get Windows 7,Office 2010 in Rs.799 Taxes :: ARTICLES ON INPUT TAX CREDIT IN VAT :: articles on VAT and GST in India :: ACCOUNTING STANDARD :: VAT Audit
News Headlines »
 CBDT issues second round of Certificates of Appreciation to tax payers for their contribution towards Nation building
 FinMin looks at cut in corporation tax
 Draft Rules for prescribing the method of valuation of fair market value in respect of the trust or the institution-Chapter XII-EB of the Income-tax Act, 1961- reg.
 India is moving towards a flawed GST
 ICAI to organise two-day international conference in Hyderabad
 Here's how to calculate tax payable on your capital gains
 Income Tax calculations for the financial year 2016-17
 CPE Events 17 October - 22 October 2016
 High Court raps I-T Department for wrong tax demand
  CBDT signs 5 advance pricing pacts with Indian taxpayers
 Finance ministry warns tax officials of action against GST protest

Pharma faces rising taxes PwC report
December, 02nd 2009

Among the plethora of challenges the pharmaceutical industry is facing, tax is going to play an increasing role in the way companies make major strategic decisions.

This is the essence of a new report from PricewaterhouseCoopers, Pharma 2020: Taxing times ahead - Which path will you take?. It notes that the global financial crisis, government pressure and changing market dynamics are likely to drive up the effective tax rate for the pharma and life sciences industry.

In a poll of 35 senior tax executives within the sector, six in ten agree that an increase in the effective tax rate is inevitable. 63% feel that the cost on their organisations might eventually be passed onto consumers unless they find ways to operate more efficiently and transform their approach to R&D and sales and marketing.

62% of tax executives polled said they are looking to maximise tax credits and other incentives for R&D and all of them believe that the demand for tax specialists will grow substantially. More than half of the respondents said they are now being consulted early on by senior management in strategic business decisions, and thus have influence over the direction of the company.

The report notes that the global recession has made tax authorities around the world hungry for new revenue sources to overcome growing budget deficits and potential new costs associated with healthcare reform initiatives. Governments are therefore focused on the use of tax havens that allow multinationals to move profits offshore and will continue to scrutinise transfer pricing practices to limit abuse of intra-company transfers of expenses or profits.

PwC adds that economic substance of offshore operations will become increasingly more important. The consultant says that identification of uncooperative nations may become more common, and corporations that continue to use tax havens could face financial penalties and reputational damage.

The study goes on to note that there has been a resurgence in mergers and acquisitions, in-licensing and joint ventures, and each of these strategies comes with significant tax implications. Also, international competition is intensifying to attract new investment, particularly from emerging markets, and while this trend may further drive profit growth to the East, companies will need to balance increased income with higher tax rates and potential price controls.

Michael Swanick, global pharmaceutical and life sciences tax leader at PwC, said that tax planning will be a critical consideration, not an afterthought, of long-term business plans to grow, buy, merge or sell and it will be one of the most important considerations in deciding where to locate intellectual property, manufacturing and service delivery.

Home | About Us | Terms and Conditions | Contact Us
Copyright 2016 CAinINDIA All Right Reserved.
Designed and Developed by Binarysoft Technologies Pvt. Ltd.
SEO Company Search Engine Optimization Company US SEO Local SEO Company Website SEO Company Alabama SEO Company Alaska SEO Company Arizona SEO Company Arkansas SEO Company California SEO Company Colorado SEO Company Connecticut SEO Company Delawa

Transfer Pricing | International Taxation | Business Consulting | Corporate Compliance and Consulting | Assurance and Risk Advisory | Indirect Taxes | Direct Taxes | Transaction Advisory | Regular Compliance and Reporting | Tax Assessments | International Taxation Advisory | Capital Structuring | Withholding tax advisory | Expatriate Tax Reporting | Litigation | Badges | Club Badges | Seals | Military Insignias | Emblems | Family Crest | Software Development India | Software Development Company | SEO Company | Web Application Development | MLM Software | MLM Solutions